Characteristics and outcomes of five patients with COVID‐19 and hematological malignancies. Issue 6 (10th June 2021)

• Record Type: Journal Article
• Authors: Citterio, Chiara; Lazzaro, Antonio; Bosi, Costanza; De Ponzio, Maurice; Cavanna, Luigi
• Is Part Of: Clinical case reports. Volume 9:Issue 6(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-06-10
• Subjects: hematology -- infectious diseases; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.4013
• Languages: English
• ISSNs: 2050-0904

Abstract

Abstract: Patients with hematological cancer are at major risk of developing infectious complication. The prevention and treatment of COVID‐19 in these patients is challenging. This experience, with the limitation of a small number of patients, highlights that early treatment of COVID‐19 can overcome the infection, also in hematological patients. Abstract : Patients with hematological cancer are at major risk of developing infectious complication. The prevention and treatment of COVID‐19 in these patients is challenging. This experience, with the limitation of a small number of patients, highlights that early treatment of COVID‐19 can overcome the infection, also in hematological patients.